Market research
SAB.F Sonic Healthcare Limited
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6B
- P/E ratio
- 15.88
- Analyst target
- Not available
- Dividend yield
- 9.6%
- Beta
- 0.57
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- AU000000SHL7
- Market cap
- 6B
- P/E ratio
- 15.88
- Analyst target
- Not available
- Dividend yield
- 9.6%
- Beta
- 0.57
About
About Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
Research context
Sonic Healthcare Limited appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the SAB.F discussion.
5 years, 7 months ago
Sonic Healthcare Limited is currently in a long term uptrend where the price is trading 8.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Sonic Healthcare Limited's total revenue sank by 0.0% to $2B since the same quarter in the previous year.
Its net income has dropped by 0.0% to $127M since the same quarter in the previous year.
Finally, its free cash flow grew by 67.0% to $333M since the same quarter in the previous year.
Based on the above factors, Sonic Healthcare Limited gets an overall score of 3/5.